- Home
- ATYR vs CRNC Comparison
ATYR vs CRNC Comparison
Compare ATYR & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- CRNC
- Stock Information
- Founded
- ATYR 2005
- CRNC 2020
- Country
- ATYR United States
- CRNC United States
- Employees
- ATYR N/A
- CRNC 1400
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- CRNC EDP Services
- Sector
- ATYR Health Care
- CRNC Technology
- Exchange
- ATYR Nasdaq
- CRNC Nasdaq
- Market Cap
- ATYR 451.3M
- CRNC 403.2M
- IPO Year
- ATYR 2015
- CRNC N/A
- Fundamental
- Price
- ATYR $4.78
- CRNC $8.77
- Analyst Decision
- ATYR Strong Buy
- CRNC Buy
- Analyst Count
- ATYR 6
- CRNC 6
- Target Price
- ATYR $20.20
- CRNC $10.00
- AVG Volume (30 Days)
- ATYR 5.8M
- CRNC 1.8M
- Earning Date
- ATYR 08-12-2025
- CRNC 08-06-2025
- Dividend Yield
- ATYR N/A
- CRNC N/A
- EPS Growth
- ATYR N/A
- CRNC N/A
- EPS
- ATYR N/A
- CRNC N/A
- Revenue
- ATYR N/A
- CRNC $254,250,000.00
- Revenue This Year
- ATYR $551.06
- CRNC N/A
- Revenue Next Year
- ATYR $1,874.58
- CRNC $7.31
- P/E Ratio
- ATYR N/A
- CRNC N/A
- Revenue Growth
- ATYR N/A
- CRNC N/A
- 52 Week Low
- ATYR $1.67
- CRNC $2.34
- 52 Week High
- ATYR $7.29
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- ATYR 43.43
- CRNC 43.41
- Support Level
- ATYR $5.46
- CRNC $8.35
- Resistance Level
- ATYR $7.29
- CRNC $9.54
- Average True Range (ATR)
- ATYR 0.64
- CRNC 0.46
- MACD
- ATYR -0.13
- CRNC -0.12
- Stochastic Oscillator
- ATYR 0.80
- CRNC 22.22
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.